{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:44:46Z","timestamp":1791171886139,"version":"4.1.0"},"reference-count":24,"publisher":"American Diabetes Association","issue":"6","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,6,1]]},"abstract":"<jats:p>OBJECTIVE\u2014Diabetes is associated with increased risk of urinary incontinence. It is unknown whether women with pre-diabetes, or impaired fasting glucose (IFG), have increased prevalence of incontinence. We determined the prevalence of, and risk factors for, incontinence among U.S. women with diabetes and IFG.<\/jats:p>\n               <jats:p>RESEARCH DESIGN AND METHODS\u2014The 2001\u20132002 National Health and Nutrition Examination Survey measured fasting plasma glucose and obtained information about diabetes and urinary incontinence among 1,461 nonpregnant adult women. Self-reported weekly or more frequent incontinence, both overall and by type (urge and stress), was our outcome.<\/jats:p>\n               <jats:p>RESULTS\u2014Of the 1,461 women, 17% had diabetes and 11% met criteria for IFG. Prevalence of weekly incontinence was similar among women in these two groups (35.4 and 33.4%, respectively) and significantly higher than among women with normal fasting glucose (16.8%); both urge and stress incontinence were increased. In addition to well-recognized risk factors including age, weight, and oral estrogen use, two microvascular complications caused by diabetes, specifically macroalbuminuria and peripheral neuropathic pain, were associated with incontinence.<\/jats:p>\n               <jats:p>CONCLUSIONS\u2014Physicians should be alert for incontinence, an often unrecognized and therefore undertreated disorder, among women with diabetes and IFG, in particular those with microvascular complications. The additional prospect of improvements in their incontinence may help motivate some high-risk women to undertake difficult lifestyle changes to reduce their more serious risk of diabetes and its sequelae.<\/jats:p>","DOI":"10.2337\/dc05-2463","type":"journal-article","created":{"date-parts":[[2006,5,27]],"date-time":"2006-05-27T00:32:06Z","timestamp":1148689926000},"page":"1307-1312","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":117,"title":["Prevalence and Risk Factors for Urinary Incontinence in Women With Type 2 Diabetes and Impaired Fasting Glucose"],"prefix":"10.2337","volume":"29","author":[{"given":"Jeanette S.","family":"Brown","sequence":"first","affiliation":[{"name":"UCSF Women\u2019s Health Clinical Research Center, University of California, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Vittinghoff","sequence":"additional","affiliation":[{"name":"UCSF Women\u2019s Health Clinical Research Center, University of California, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Lin","sequence":"additional","affiliation":[{"name":"UCSF Women\u2019s Health Clinical Research Center, University of California, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leroy M.","family":"Nyberg","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes, Digestive, and Kidney Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Kusek","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes, Digestive, and Kidney Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alka M.","family":"Kanaya","sequence":"additional","affiliation":[{"name":"UCSF Women\u2019s Health Clinical Research Center, University of California, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031216410637200_R1","doi-asserted-by":"crossref","unstructured":"Sampselle CM, Harlow SD, Skurnick J, Brubaker L, Bondarenko I: Urinary incontinence predictors and life impact in ethnically diverse perimenopausal women. Obstet Gynecol\u2008100: 1230\u20131238, 2002","DOI":"10.1097\/00006250-200212000-00013"},{"key":"2022031216410637200_R2","unstructured":"Varmus H: Disease-Specific Estimates of Direct and Indirect Costs of Illness and NIH Support. Bethesda, MD, Department of Health and Human Services, National Institutes of Health, 1997, p. Appendix"},{"key":"2022031216410637200_R3","doi-asserted-by":"crossref","unstructured":"Wilson L, Brown JS, Shin GP, Luc KO, Subak LL: Annual direct cost of urinary incontinence. Obstet Gynecol\u200898:398\u2013406, 2001","DOI":"10.1097\/00006250-200109000-00007"},{"key":"2022031216410637200_R4","doi-asserted-by":"crossref","unstructured":"Davidson MB, Landsman PB, Alexander CM: Lowering the criterion for impaired fasting glucose will not provide clinical benefit (Letter). Diabetes Care\u200826:3329\u20133330, 2003","DOI":"10.2337\/diacare.26.12.3329"},{"key":"2022031216410637200_R5","doi-asserted-by":"crossref","unstructured":"Benjamin SM, Valdez R, Geiss LS, Rolka DB, Narayan KM: Estimated number of adults with prediabetes in the U.S. in 2000: opportunities for prevention. Diabetes Care\u200826:645\u2013649, 2003","DOI":"10.2337\/diacare.26.3.645"},{"key":"2022031216410637200_R6","doi-asserted-by":"crossref","unstructured":"Jackson RA, Vittinghoff E, Kanaya AM, Miles TP, Resnick HE, Kritchevsky SB, Simonsick EM, Brown JS: Urinary incontinence in elderly women: findings from the Health, Aging, and Body Composition Study. Obstet Gynecol\u2008104:301\u2013307, 2004","DOI":"10.1097\/01.AOG.0000133482.20685.d1"},{"key":"2022031216410637200_R7","doi-asserted-by":"crossref","unstructured":"Lifford KL, Curhan GC, Hu FB, Barbieri RL, Grodstein F: Type 2 diabetes mellitus and risk of developing urinary incontinence. J Am Geriatr Soc\u200853:1851\u20131857, 2005","DOI":"10.1111\/j.1532-5415.2005.53565.x"},{"key":"2022031216410637200_R8","doi-asserted-by":"crossref","unstructured":"Jackson SL, Scholes D, Boyko EJ, Abraham L, Fihn SD: Urinary incontinence and diabetes in postmenopausal women. Diabetes Care\u200828:1730\u20131738, 2005","DOI":"10.2337\/diacare.28.7.1730"},{"key":"2022031216410637200_R9","doi-asserted-by":"crossref","unstructured":"Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care\u200820:1183\u20131197, 1997","DOI":"10.2337\/diacare.20.7.1183"},{"key":"2022031216410637200_R10","doi-asserted-by":"crossref","unstructured":"Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care\u200826:3160\u20133167, 2003","DOI":"10.2337\/diacare.26.11.3160"},{"key":"2022031216410637200_R11","doi-asserted-by":"crossref","unstructured":"Chavers BM, Simonson J, Michael AF: A solid phase fluorescent immunoassay for the measurement of human urinary albumin. Kidney Int\u200825:576\u2013578, 1984","DOI":"10.1038\/ki.1984.57"},{"key":"2022031216410637200_R12","unstructured":"National Center for Health Statistics: National Health and Nutrition Examination Survey. Atlanta, GA, Centers for Disease Control and Prevention, 2001"},{"key":"2022031216410637200_R13","doi-asserted-by":"crossref","unstructured":"Grady D, Brown JS, Vittinghoff E, Applegate W, Varner E, Snyder T: Postmenopausal hormones and incontinence: the Heart and Estrogen\/Progestin Replacement Study. Obstet Gynecol\u200897:116\u2013120, 2001","DOI":"10.1097\/00006250-200101000-00023"},{"key":"2022031216410637200_R14","doi-asserted-by":"crossref","unstructured":"Nakayama H, Jorgensen HS, Pedersen PM, Raaschou HO, Olsen TS: Prevalence and risk factors of incontinence after stroke: the Copenhagen Stroke Study. Stroke\u200828:58\u201362, 1997","DOI":"10.1161\/01.STR.28.1.58"},{"key":"2022031216410637200_R15","doi-asserted-by":"crossref","unstructured":"Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK: Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA\u2008263:2893\u20132898, 1990","DOI":"10.1001\/jama.263.21.2893"},{"key":"2022031216410637200_R16","doi-asserted-by":"crossref","unstructured":"Kaplan SA, Te AE, Blaivas JG: Urodynamic findings in patients with diabetic cystopathy. J Urol\u2008153:342\u2013344, 1995","DOI":"10.1097\/00005392-199502000-00013"},{"key":"2022031216410637200_R17","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33): UK Prospective Diabetes Study (UKPDS) Group. Lancet\u2008352:837\u2013853, 1998 [erratum in Lancet\u2008354:602, 1999]","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"2022031216410637200_R18","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ\u2008317:703\u2013713, 1998 [erratum in BMJ\u2008318:29, 1999]","DOI":"10.1136\/bmj.317.7160.703"},{"key":"2022031216410637200_R19","doi-asserted-by":"crossref","unstructured":"Subak LL, Whitcomb E, Shen H, Saxton J, Vittinghoff E, Brown JS: Weight loss: a novel and effective treatment for urinary incontinence. J Urol\u2008174:190\u2013195, 2005","DOI":"10.1097\/01.ju.0000162056.30326.83"},{"key":"2022031216410637200_R20","doi-asserted-by":"crossref","unstructured":"Brown JS, Wing R, Barrett-Connor E, Nyberg LM, Kusek JW, Orchard TJ, Ma Y, Vittinghoff E, Kanaya AM: Lifestyle intervention is associated with lower prevalence of urinary incontinence: the diabetes prevention program. Diabetes Care\u200829:385\u2013390, 2006","DOI":"10.2337\/diacare.29.02.06.dc05-1781"},{"key":"2022031216410637200_R21","doi-asserted-by":"crossref","unstructured":"Ryan DH, Espeland MA, Foster GD, Haffner SM, Hubbard VS, Johnson KC, Kahn SE, Knowler WC, Yanovski SZ: Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials\u200824:610\u2013628, 2003","DOI":"10.1016\/S0197-2456(03)00064-3"},{"key":"2022031216410637200_R22","doi-asserted-by":"crossref","unstructured":"Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med\u2008346:393\u2013403, 2002","DOI":"10.1056\/NEJMoa012512"},{"key":"2022031216410637200_R23","doi-asserted-by":"crossref","unstructured":"Hendrix SL, Cochrane BB, Nygaard IE, Handa VL, Barnabei VM, Iglesia C, Aragaki A, Naughton MJ, Wallace RB, McNeeley SG: Effects of estrogen with and without progestin on urinary incontinence. JAMA\u2008293:935\u2013948, 2005","DOI":"10.1001\/jama.293.8.935"},{"key":"2022031216410637200_R24","doi-asserted-by":"crossref","unstructured":"Malmberg K, Yusuf S, Gerstein HC, Brown J, Zhao F, Hunt D, Piegas L, Calvin J, Keltai M, Budaj A: Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation\u2008102:1014\u20131019, 2000","DOI":"10.1161\/01.CIR.102.9.1014"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/29\/6\/1307\/592926\/zdc00606001307.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/29\/6\/1307\/592926\/zdc00606001307.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T17:13:54Z","timestamp":1647105234000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/29\/6\/1307\/24959\/Prevalence-and-Risk-Factors-for-Urinary"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6,1]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc05-2463","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6,1]]}}}